Literature DB >> 28420070

Lower kidney allograft survival in African-Americans compared to Hispanic-Americans with lupus.

M L Gonzalez-Suarez1, G Contreras2.   

Abstract

Background and objective African-Americans and Hispanic-Americans with lupus are the two most common minority groups who receive kidney transplants in the USA. It is unknown if African-Americans and Hispanic-Americans with lupus have similar outcomes after kidney transplantation. In this study, we assessed whether African-Americans compared to Hispanic-Americans have worse kidney allograft survival after risk factors of rejection and other prognostic factors were matched between both groups. Methods Out of 1816 African-Americans and 901 Hispanic-Americans with lupus, who received kidney transplants between 1987 and 2006 and had complete records in the UNOS program, 478 pairs were matched in 16 baseline predictors and follow-up time employing a predicted probability of group membership. The primary outcome was kidney allograft survival. Main secondary outcomes were rejection, allograft failure attributed to rejection, and mortality. Results Matched pairs were predominantly women (81%) with the mean age of 36 years. 96% were on dialysis before transplantation. 89% of recipients received kidneys from deceased donors and 15.5% from expanded criteria donors. 12% of recipients had zero HLA mismatch. African-Americans compared to Hispanic-Americans had lower cumulative allograft survival during 12-year follow-up ( p < 0.001). African-Americans compared to Hispanic-Americans had higher rates of rejection (10.4 vs 6.73 events/100 patients-years; p = 0.0002) and allograft failure attributed to rejection (6.31 vs 3.99; p = 0.0023). However, African-Americans and Hispanic-Americans had similar mortality rates (2.71 vs 2.31; p = 0.4269). Conclusions African-Americans compared to Hispanic-Americans with lupus had lower kidney allograft survival when recognized risk factors of rejection were matched between groups.

Entities:  

Keywords:  Ancestry; kidney transplantation outcomes; lupus nephritis

Mesh:

Year:  2017        PMID: 28420070     DOI: 10.1177/0961203317699287

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  2 in total

1.  Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.

Authors:  April M Jorge; Ronald B Melles; Yuqing Zhang; Na Lu; Sharan K Rai; Lucy H Young; Karen H Costenbader; Rosalind Ramsey-Goldman; S Sam Lim; John M Esdaile; Ann E Clarke; M B Urowitz; Anca Askanase; Cynthia Aranow; Michelle Petri; Hyon Choi
Journal:  Arthritis Res Ther       Date:  2018-07-05       Impact factor: 5.156

Review 2.  Update on lupus epidemiology: advancing health disparities research through the study of minority populations.

Authors:  Cristina Drenkard; S Sam Lim
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.